• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP Back to Search Results
Catalog Number JHH101002J
Device Problems Patient-Device Incompatibility (2682); No Apparent Adverse Event (3189)
Patient Problem Occlusion (1984)
Event Date 08/01/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4) the lot number was not provided.Therefore the udi is not available.The review of the manufacturing paperwork could not be performed as the lot number(s) were not available.According to the gore® viabahn® endoprosthesis instructions for use (ifu), device-related complications and adverse events include, but are not limited to thrombosis or occlusion of device.
 
Event Description
On (b)(6) 2017, this patient underwent endovascular procedure to repair a traumatic pseudoaneurysm of the right subclavian artery using a gore® viabahn® endoprosthesis.There was a thrombotic occlusion distal to the pseudoaneurysm, and thrombectomy was performed with a fogarty catheter from the right brachial artery approach prior to a delivery of the endoprosthesis.The patient tolerated the procedure.On an unknown date around august, follow-up computed tomography (ct) showed a stenosis of the endoprosthesis.The patient was taking mono antiplatelet (bay aspirin), and plavix was additionally administered at that time.On (b)(6) 2017, it was reported that the latest ct (date unknown) confirmed an occlusion of the endoprosthesis.Noac was additionally administered.No clinical symptoms were reportedly observed, and the patient is being monitored.Reportedly, the physician suspected that the event was contributed by the patient's predisposition since the occlusion occurred even with dual-antiplatelet drugs.Also, the lesion was reportedly located near the shoulder joint, and this condition reportedly may have contributed to the event as well.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
marcos ayala
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key7030846
MDR Text Key92015625
Report Number2017233-2017-00596
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 10/19/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/14/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberJHH101002J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-